about
Origin and diffusion of mtDNA haplogroup XThe western and eastern roots of the Saami--the story of genetic "outliers" told by mitochondrial DNA and Y chromosomesPhylogeography of Y-chromosome haplogroup I reveals distinct domains of prehistoric gene flow in europeMitochondrial DNA variations in Russian and Belorussian populationsComparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancerBreast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium11q13 is a susceptibility locus for hormone receptor positive breast cancer.Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.Prediction of breast cancer risk based on profiling with common genetic variantsGenome-wide association analysis identifies three new breast cancer susceptibility loci.9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer.Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.Origin and spread of human mitochondrial DNA haplogroup U7.Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe.Association analysis identifies 65 new breast cancer risk loci.Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Rare occurrence of PALB2 mutations in ovarian cancer patients from the Volga-Ural region.Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations.Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe.Genes reveal traces of common recent demographic history for most of the Uralic-speaking populationsCorrection: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genesPolygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesAssociations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysisGenome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
P50
Q24532226-4937A927-CC32-4DA6-A1D7-4062717F58E3Q24533322-9C5782E1-6AA1-4641-9032-50EE62B73F3EQ24533494-CE5C3FCF-0CDA-479D-9242-DF94ED146A81Q28242469-0703FD87-87C9-413D-97BF-D4BEDDD8EFA1Q31082788-D7D676AA-DE4A-45AA-922D-1986F2CACD2FQ34181322-7CD57B97-6D4B-43D2-AD41-CF3AA2C499AFQ34327945-700DC788-06B9-4843-9D76-0515637D8991Q35532898-F08F3D9E-D330-418B-AFF1-88AD9E265ABAQ36016386-2A96567A-BEA9-4BAE-A640-E6D32D671B43Q36086247-B7465842-4193-4823-BE0E-91D6D216A8F0Q36583004-B6515C30-9014-4EF9-A11E-8EE64F7DD2BAQ36842233-D293D788-6761-4AD2-BAFB-08A5B5A5757FQ37169873-095D0040-3EB4-4622-9749-C0FAE586E0F8Q37300024-F60D751E-BD2C-4EC5-BF87-CABEA80E393BQ37356243-26F69129-521B-4916-B7B7-B696B5EC9FF6Q37499453-D2EB0F79-CA27-4382-B220-28EE81A20CC0Q37739048-42FDAA1A-C18C-4DF9-A9A8-8ACA962D04A0Q37741283-6DECB38F-B274-498F-899D-BFF98D48C2E8Q39437211-F645068B-B0B1-4EDB-8544-A4B33EB03546Q44242400-82CE449B-A38D-40F2-862E-109FB5DCED3DQ45979098-A685DF54-7682-4D59-8FC0-371F7518636DQ46103372-A2F6C298-3D22-4CFA-AAF5-4F181F9CEA41Q46760859-C34BD9CA-E950-4873-8B66-96FF41FB7E49Q47847793-3663FAFD-E139-408E-AF79-C1BE3CBA287BQ51116126-EDA936D5-0C19-456E-83B1-9CBD38B334C9Q57094116-1B7F71F6-7F9D-4451-B1EA-E4B7C4247B8DQ57278898-2D906760-7AF5-41C4-8A97-18C25D3B940DQ61230414-D924F6FC-4411-4F2A-A89F-56FF9FAB17F6Q62583133-91E5C4E7-6441-4CD3-BE40-7446BD28A8F2Q62583318-3086FB7C-A598-488D-A19B-6F1566F33B4BQ63681757-BD7B37F5-93DA-4518-AFDA-A9DE6A74D489
P50
description
onderzoeker
@nl
name
Marina Alexejewna Bermischewa
@de
Marina Bermisheva
@ast
Marina Bermisheva
@en
Marina Bermisheva
@es
Marina Bermisheva
@nl
Marina Bermisheva
@sl
Марина Алексеевна Бермишева
@ru
type
label
Marina Alexejewna Bermischewa
@de
Marina Bermisheva
@ast
Marina Bermisheva
@en
Marina Bermisheva
@es
Marina Bermisheva
@nl
Marina Bermisheva
@sl
Марина Алексеевна Бермишева
@ru
altLabel
Marina Alekseyevna Bermisheva
@en
Marina Bermischewa
@de
prefLabel
Marina Alexejewna Bermischewa
@de
Marina Bermisheva
@ast
Marina Bermisheva
@en
Marina Bermisheva
@es
Marina Bermisheva
@nl
Marina Bermisheva
@sl
Марина Алексеевна Бермишева
@ru